Literature DB >> 29165597

GSTA1 Expression Is Correlated With Aldosterone Level in KCNJ5-Mutated Adrenal Aldosterone-Producing Adenoma.

Xintao Li1, Baojun Wang1, Lu Tang1, Yu Zhang1, Luyao Chen1, Liangyou Gu1, Fan Zhang1, Jinzhi Ouyang2, Xu Zhang1.   

Abstract

Context: KCNJ5 mutation is a major cause of aldosterone-producing adenomas (APAs). The development of APA apart from KCNJ5 mutation is less investigated. Objective: To investigate other mechanisms affecting aldosterone secretion apart from KCNJ5. Patients and
Methods: Six pairs of KCNJ5-mutated, high and low aldosterone-secreting APAs, five non-KCNJ5-mutated APAs, and four normal adrenal glands were assayed by Affymetrix GeneChip Human Transcriptome Array 2.0. A total of 113 APA samples were investigated to explore the expression of glutathione-S-transferase A1 (GSTA1). H295R cells were used to verify the function of GSTA1.
Results: GSTA1 was the top gene downregulated in high-aldosterone KCNJ5-mutated APAs. GSTA1 was also downregulated in KCNJ5-mutated APAs compared with wild-type KCNJ5 APAs. Accordingly, mutant KCNJ5 decreased GSTA1 messenger RNA and protein expression levels. GSTA1 overexpression suppressed aldosterone secretion whether in wild-type or mutant KCNJ5 H295R cells. Adding ethacrynic acid or silencing of GSTA1 increased aldosterone secretion by increasing reactive oxygen species (ROS), superoxide, H2O2 levels, and Ca2+ influx. The expression of the transcription factors NR4A1, NR4A2, and CAMK1 and intracellular Ca2+ were significantly upregulated by GSTA1 inhibition. The reduced form of NAD phosphate oxidase inhibitor or H2O2 scavenger or blocking calmodulin or calcium channels could significantly reduce aldosterone secretion in GSTA1-inhibited cells. Conclusions: (1) GSTA1 expression is reversely correlated with aldosterone level in KCNJ5-mutated APAs, (2) GSTA1 regulates aldosterone secretion by ROS and Ca2+ signaling, and (3) KCNJ5 mutation downregulates GSTA1 expression, and overexpression of GSTA1 reverses increased aldosterone in KCNJ5-mutated adrenal cells.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 29165597     DOI: 10.1210/jc.2017-00950

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  4 in total

Review 1.  The landscape of molecular mechanism for aldosterone production in aldosterone-producing adenoma.

Authors:  Kenji Oki; Celso E Gomez-Sanchez
Journal:  Endocr J       Date:  2020-09-24       Impact factor: 2.860

Review 2.  Update on Genetics of Primary Aldosteronism.

Authors:  Kiyotaka Itcho; Kenji Oki; Haruya Ohno; Masayasu Yoneda
Journal:  Biomedicines       Date:  2021-04-10

Review 3.  Comparative Genomics and Transcriptome Profiling in Primary Aldosteronism.

Authors:  Elke Tatjana Aristizabal Prada; Isabella Castellano; Eva Sušnik; Yuhong Yang; Lucie S Meyer; Martina Tetti; Felix Beuschlein; Martin Reincke; Tracy A Williams
Journal:  Int J Mol Sci       Date:  2018-04-09       Impact factor: 5.923

4.  BRD9 controls the oxytocin signaling pathway in gastric cancer via CANA2D4, CALML6, GNAO1, and KCNJ5.

Authors:  Yuan Wang; Xue-Yan Jiang; Xi-Yong Yu
Journal:  Transl Cancer Res       Date:  2020-05       Impact factor: 1.241

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.